When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'

被引:11
作者
Gyorki, David E. [1 ,2 ]
Barbour, Andrew [3 ,4 ]
Hanikeri, Mark [5 ]
Mar, Victoria [6 ,7 ,8 ]
Sandhu, Shahneen [9 ]
Thompson, John F. [10 ,11 ,12 ]
机构
[1] Univ Melbourne, Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
[3] Univ Queensland, Princess Alexandra Hosp, Upper Gastrointestinal & Soft Tissue Unit, Brisbane, Qld, Australia
[4] Univ Queensland, Discipline Surg, Surg Oncol Lab, Brisbane, Qld, Australia
[5] Western Australia Melanoma Advisory Serv, Perth, WA, Australia
[6] Monash Univ, Alfred Hosp, Victorian Melanoma Serv, Melbourne, Vic, Australia
[7] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
[8] Skin & Canc Fdn Inc, Melbourne, Vic, Australia
[9] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia
[10] Univ Sydney, Melanoma Inst Australia, Poche Ctr, Sydney, NSW, Australia
[11] Univ Sydney, Discipline Surg, Sydney, NSW, Australia
[12] Royal Prince Alfred Hosp, Dept Melanoma & Surg Oncol, Sydney, NSW, Australia
关键词
guidelines; melanoma; sentinel node biopsy; THIN MELANOMAS; POSITIVITY; SURVIVAL; TRIAL;
D O I
10.1111/ajd.12662
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A sentinel lymph node biopsy is a surgical staging procedure performed for patients with primary cutaneous melanoma who are clinically lymph-node negative to determine whether there is low volume nodal metastasis in the draining lymph node field. A systematic review was recently performed to update the Australian clinical practice guidelines for the diagnosis and management of melanoma, addressing the question, 'When is a sentinel lymph node biopsy indicated?' This article discusses the findings of the systematic review and the evidence base for the updated guidelines.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 19 条
  • [1] Latent Subgroup Analysis of a Randomized Clinical Trial through a Semiparametric Accelerated Failure Time Mixture Model
    Altstein, L.
    Li, G.
    [J]. BIOMETRICS, 2013, 69 (01) : 52 - 61
  • [2] Amin M.B., 2017, AM JOINT COMMITTEE C, V8th
  • [3] Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
    Azimi, Farhad
    Scolyer, Richard A.
    Rumcheva, Pavlina
    Moncrieff, Marc
    Murali, Rajmohan
    McCarthy, Stanley W.
    Saw, Robyn P.
    Thompson, John F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2678 - 2683
  • [4] Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy
    Bartlett, Edmund K.
    Gimotty, Phyllis A.
    Sinnamon, Andrew J.
    Wachtel, Heather
    Roses, Robert E.
    Schuchter, Lynn
    Xu, Xiaowei
    Elder, David E.
    Ming, Michael
    Elenitsas, Rosalie
    Guerry, DuPont
    Kelz, Rachel R.
    Czerniecki, Brian J.
    Fraker, Douglas L.
    Karakousis, Giorgos C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 643 - 649
  • [5] Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1845 - 1855
  • [6] Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool
    Gyorki, David E.
    Sanelli, Alexandra
    Herschtal, Alan
    Lazarakis, Smaro
    McArthur, Grant A.
    Speakman, David
    Spillane, John
    Henderson, Michael A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) : 579 - 584
  • [7] Gyorki DE, 2016, CLINI PRACTICE GUIDE
  • [8] Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
    Han, Dale
    Zager, Jonathan S.
    Shyr, Yu
    Chen, Heidi
    Berry, Lynne D.
    Iyengar, Sanjana
    Djulbegovic, Mia
    Weber, Jaimie L.
    Marzban, Suroosh S.
    Sondak, Vernon K.
    Messina, Jane L.
    Vetto, John T.
    White, Richard L.
    Pockaj, Barbara
    Mozzillo, Nicola
    Charney, Kim James
    Avisar, Eli
    Krouse, Robert
    Kashani-Sabet, Mohammed
    Leong, Stanley P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : 4387 - 4393
  • [9] Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection
    Kretschmer, Lutz
    Thoms, Kai-Martin
    Peeters, Sabine
    Haenssle, Holger
    Bertsch, Hans-Peter
    Emmert, Steffen
    [J]. MELANOMA RESEARCH, 2008, 18 (01) : 16 - 21
  • [10] Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
    Morton, D. L.
    Thompson, J. F.
    Cochran, A. J.
    Mozzillo, N.
    Nieweg, O. E.
    Roses, D. F.
    Hoekstra, H. J.
    Karakousis, C. P.
    Puleo, C. A.
    Coventry, B. J.
    Kashani-Sabet, M.
    Smithers, B. M.
    Paul, E.
    Kraybill, W. G.
    McKinnon, J. G.
    Wang, H. -J.
    Elashoff, R.
    Faries, M. B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (07) : 599 - 609